Abstract
Telomerase is reactivated in lung cancer cells, the most prevalent cancer worldwide, but not normal cells. Therefore, targeting it, preferably with natural compounds derive from medicinal plant such as curcumin, could have important effect on treatment of lung cancer. Curcumin, derived from Curcuma longarhizome, has many anti-cancer activities. Therefore, the main objective of current work was to study inhibitory effect of C. longa total extract on telomerase in A549 lung cancer cell line as in vitro model of lung cancer. First, total extract of C. longawere prepared by n-hexane, methanol and dichloromethane. Then, cytotoxic effect of n-hexane phase was studied on A549 lung cancer cell line with 24, 48 and 72 h MTT assays. Finally, after determination of IC50, cells were treated with n-hexane extract and TRAP (Telomeric Repeat Amplification Protocol) assay was done to measure amount of relative telomerase inhibition by the extract. Data analysis showed that n-hexane extract of C. longa has dose-dependent cytotoxic effect on A549 lung cancer cell line with IC50 = 0.23 - 0.28 mg/ml and the extract inhibits telomerase activity with dose-dependent manner. In conclusion, n-hexane extract ofC. longa has cytotoxic and telomerase-inhibitory effect on cell line A549 and could be exploited as potential source for developing novel drugs against lung cancer. Key words: Telomerase, lung cancer, Curcuma longa, A549 lung cancer cell line.
Highlights
Telomerase is a ribonucleoprotein reverse transcriptase which maintains telomeric ends of eukaryotic chromosomes during DNA replication
Data analysis of cytotoxicity assay showed that IC50 of nhexane extract on A549 lung cancer cell line is 0.28, 0.27 and 0.23 mg/ml for 24, 48 and 72 h MTT assays, respectively (Figure 2)
MTT assay showed that n-hexane extract of C. longa has dose-dependent but not timedependent cytotoxicity on the A549 lung cancer cell line (IC50 = 0.23 to 0.30 mg/ml)
Summary
Telomerase is a ribonucleoprotein reverse transcriptase which maintains telomeric ends of eukaryotic chromosomes during DNA replication. Different agents have been proposed for telo-merase inhibition (Strahl and Blackburn, 1996; Damm et al, 2001; Zou et al, 2006; Massard et al, 2006; Nakamura et al, 2005; Mizushina et al, 2000; Yeo et al, 2005). They have undesirable complications (Mittal et al, 2004) and it is necessary to seek alternative telomerase-inhibiting agents, preferably natural compounds such as curcumin
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
